A complete battery of geriatric and psychometric tests was used to determine whether plasma-borne zinc (Zn), a key ion in neuroplasticity, can be associated with the severity of functional, psychological and cognitive impairment in non-demented older individuals. There was a significant positive correlation between plasma Zn levels and the concentration subcategory measured with the Mini-Mental State Examination (MMSE) test (p < 0.001), but not the total MMSE score, and the levels were significantly reduced in polymedicated patients (defined as concurrent administration of >5 drugs). No correlations were found between plasma Zn levels and depressive symptoms measured with the Yesavage scale for geriatric depression or the Barthel Index - a measurement of the ability of individuals to perform the activities of daily living. Depressive symptoms were associated with poor sleep quality and polymedication (p < 0.001 and p < 0.05, respectively). Our results suggest that peripheral Zn concentration may play a role in the physiopathology of some domain of cognitive function. No correlation to depressive symptoms in the geriatric population under antidepressant drug treatment was observed. However, further studies are needed to understand the relationship between circulating Zn and concentration deficits in order to determine whether Zn represents a candidate early biomarker for cognitive impairment.
Experimental Gerontology – Elsevier
Published: Jul 15, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera